Senneville, E.
Publications
Autres publications scientifiques
PS28
J Antimicrob Chemother 2023, 78(12):2919-2925.
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
Hervochon, C.
|
Hennart, B.
|
Leroy, A.-G.
|
Corvec, S.
|
Boutoille, D.
|
Senneville, E.
|
Sotto, A.
|
Illes, G.
|
Chavanet, P.
|
Dubée, V.
|
Bleibtreu, A.
|
De Carné, M.-C.
|
Talarmin, J.-P.
|
Revest, M.
|
Castan, B.
|
Bellouard, R.
|
Dailly, E.
|
Allorge, D.
|
Dinh, A.
|
Le Turnier, P.
|
Grégoire, M.
https://doi.org/10.1093/jac/dkad331
PS27
Int J Antimicrob Agents 2023, 62(5):106960.
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel.
Senneville, E.
|
Cuervo, G.
|
Grégoire, M.
|
Hidalgo-Tenorio, C.
|
Jehl, F.
|
Miro, J.-M.
|
Seaton, A.
|
Söderquist, B.
|
Soriano, A.
|
Thalhammer, F.
|
Pea, F.
https://doi.org/10.1016/j.ijantimicag.2023.106960
Brevets
Thèse